• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Surgery Partners Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8/5/25 7:34:10 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care
    Get the next $SGRY alert in real time by email
    sgry-20250805
    0001638833FALSE00016388332025-08-052025-08-05

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    Form 8-K

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the
    Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): August 5, 2025
    Surgery Partners, Inc.
    (Exact Name of Registrant as Specified in Charter)
    Delaware001-3757647-3620923
    (State or Other Jurisdiction
    of Incorporation)
    (Commission
    File Number)
    (IRS Employer
    Identification No.)
    340 Seven Springs Way, Suite 600
    Brentwood, Tennessee 37027
    (Address of Principal Executive Offices) (Zip Code)
    (615) 234-5900
    (Registrant’s Telephone Number, Including Area Code)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common Stock, par value $0.01 per shareSGRYThe Nasdaq Global Select Market
    Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    Item 2.02 Results of Operations and Financial Condition.
    On August 5, 2025, Surgery Partners, Inc. issued a press release announcing results for the three and six months ended June 30, 2025. See the press release attached as Exhibit 99.1.
    In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.
    Surgery Partners makes reference to non-GAAP financial measures in the attached press release and a reconciliation of such non-GAAP financial measures to the most directly comparable GAAP financial measures is provided therein.
    Item 9.01. Financial Statements and Exhibits.
    (d) Exhibits:
    99.1
    Press release dated August 5, 2025
    104Cover Page Interactive Data File (embedded within the Inline XBRL document)



    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    SURGERY PARTNERS, INC.
    Date:
    August 5, 2025By:/s/ David T. Doherty
    David T. Doherty
    Executive Vice President and Chief Financial Officer


    Get the next $SGRY alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SGRY

    DatePrice TargetRatingAnalyst
    7/28/2025$28.00Buy
    BofA Securities
    12/16/2024$30.00Buy
    BofA Securities
    10/14/2024$38.00Buy
    UBS
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    6/28/2024$31.00Outperform
    Macquarie
    3/6/2024$35.00Equal Weight
    Barclays
    11/14/2023$39.00 → $35.00Market Perform → Outperform
    TD Cowen
    6/2/2023$42.00 → $45.00Neutral → Buy
    BofA Securities
    More analyst ratings

    $SGRY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities resumed coverage on Surgery Partners with a new price target

    BofA Securities resumed coverage of Surgery Partners with a rating of Buy and set a new price target of $28.00

    7/28/25 9:00:02 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    BofA Securities initiated coverage on Surgery Partners with a new price target

    BofA Securities initiated coverage of Surgery Partners with a rating of Buy and set a new price target of $30.00

    12/16/24 6:50:04 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    UBS initiated coverage on Surgery Partners with a new price target

    UBS initiated coverage of Surgery Partners with a rating of Buy and set a new price target of $38.00

    10/14/24 7:41:50 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    $SGRY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Director Maryland Patricia Anne sold 0 shares (SEC Form 4)

    4/A - Surgery Partners, Inc. (0001638833) (Issuer)

    8/15/25 6:31:14 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Director Deluca Teresa sold $455,209 worth of shares (20,018 units at $22.74), decreasing direct ownership by 31% to 45,173 units (SEC Form 4)

    4 - Surgery Partners, Inc. (0001638833) (Issuer)

    8/15/25 6:31:07 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Director Maryland Patricia Anne sold $455,209 worth of shares (20,018 units at $22.74), decreasing direct ownership by 81% to 4,565 units (SEC Form 4)

    4 - Surgery Partners, Inc. (0001638833) (Issuer)

    8/13/25 4:16:04 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    $SGRY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Surgery Partners, Inc. Announces Second Quarter 2025 Results

    BRENTWOOD, Tenn., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 8.4% for the second quarter Same-facility revenues increased 5.1% for the second quarterSame-facility cases increased 3.4% for the second quarter Net loss attributable to Surgery Partners, Inc. was $2.5 million for the second quarter Adjusted EBITDA increased 9.0% to $129.0 million for the second quarter 2025 Guidance

    8/5/25 7:30:00 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Surgery Partners, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call Details

    BRENTWOOD, Tenn., July 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2025 results before the market opens on Tuesday, August 5, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-844-826-3033 (domestic), 1-412-317-5185 (international)Replay (available 3 hours after the call and available until August 19, 2025): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 10201328 Interested in

    7/18/25 8:00:00 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    SURGERY PARTNERS, INC. and Bain Capital Conclude Discussions

    -- Board reaffirms its confidence in the Company's long-term growth prospects; Company reiterates full-year 2025 financial guidance Company expects to host an Investor Day in the second half of 2025 to discuss its future growth plans and long-term outlook -- BRENTWOOD, Tenn., June 17, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced that a Special Committee of independent directors of the Board (the "Independent Committee") and Bain Capital Private Equity, LP ("Bain Capital") have concluded discussions related to Bain Capital's non-binding proposal to acquire al

    6/17/25 8:00:00 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    $SGRY
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Surgery Partners Inc.

    SCHEDULE 13G - Surgery Partners, Inc. (0001638833) (Subject)

    8/14/25 4:07:04 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Surgery Partners Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Surgery Partners, Inc. (0001638833) (Filer)

    8/13/25 5:18:20 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Surgery Partners Inc.

    SCHEDULE 13G/A - Surgery Partners, Inc. (0001638833) (Subject)

    8/12/25 10:34:25 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    $SGRY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Surgery Partners Inc.

    SC 13G/A - Surgery Partners, Inc. (0001638833) (Subject)

    11/8/24 10:46:38 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by Surgery Partners Inc.

    SC 13G - Surgery Partners, Inc. (0001638833) (Subject)

    10/24/24 2:02:10 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G/A filed by Surgery Partners Inc. (Amendment)

    SC 13G/A - Surgery Partners, Inc. (0001638833) (Subject)

    2/13/24 5:15:54 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    $SGRY
    Financials

    Live finance-specific insights

    View All

    Surgery Partners, Inc. Announces Second Quarter 2025 Results

    BRENTWOOD, Tenn., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 8.4% for the second quarter Same-facility revenues increased 5.1% for the second quarterSame-facility cases increased 3.4% for the second quarter Net loss attributable to Surgery Partners, Inc. was $2.5 million for the second quarter Adjusted EBITDA increased 9.0% to $129.0 million for the second quarter 2025 Guidance

    8/5/25 7:30:00 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Surgery Partners, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call Details

    BRENTWOOD, Tenn., July 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2025 results before the market opens on Tuesday, August 5, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-844-826-3033 (domestic), 1-412-317-5185 (international)Replay (available 3 hours after the call and available until August 19, 2025): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 10201328 Interested in

    7/18/25 8:00:00 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Surgery Partners, Inc. Announces First Quarter 2025 Results; Reaffirms Full Year 2025 Guidance

    BRENTWOOD, Tenn., May 12, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights(All comparisons are year-over-year unless otherwise noted) Revenue increased 8.2% for the first quarter Same-facility revenues increased 5.2% for the first quarterSame-facility cases increased 6.5% for the first quarter Net loss attributable to Surgery Partners, Inc. was $37.7 million for the first quarter Adjusted EBITDA increased 6.6% to $103.9 million for the first quarter 2025 Guidan

    5/12/25 7:30:00 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    $SGRY
    Leadership Updates

    Live Leadership Updates

    View All

    Surgery Partners, Inc. Names Laura L. Forese, MD to Board of Directors

    BRENTWOOD, Tenn., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") today announced that Dr. Laura L. Forese has been appointed to serve as an independent director on its Board of Directors. Dr. Forese's appointment, which is effective January 10, 2025, will increase the size of Surgery Partners' Board to eleven members. Dr. Forese joins the Surgery Partners Board with extensive healthcare experience. Her career in healthcare administration spans over 40 years, most recently serving as an executive vice president and chief operating officer for New York-Presbyterian, one of the nation's most comprehensive, integrated academic heal

    1/13/25 5:00:24 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Teladoc Health Appoints Leading Healthcare and Hospitals Executive Eric Evans to Board of Directors

    PURCHASE, NY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today appointed Eric Evans to the company's board of directors. Mr. Evans, currently chief executive officer and director of Brentwood, TN-based Surgery Partners, Inc. (NASDAQ:SGRY), is a recognized healthcare and hospital executive with significant experience leading complex organizations operating at the intersection of care and technology. Mr. Evans joins the board following the retirement of Senator William Frist, M.D. earlier this year, and will serve on the board's compensation committee. David B. Snow, Jr., non-executive Chairman of the company's board,

    9/20/23 8:05:00 AM ET
    $SGRY
    $TDOC
    Hospital/Nursing Management
    Health Care
    Medical/Nursing Services

    Akumin Provides Business Update and Announces CFO Transition

    PLANTATION, Fla., Aug. 12, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") provided a business update and announced the termination of employment of its Chief Financial Officer, William Larkin and the appointment of David Kretschmer as Interim Chief Financial Officer, effective today. The Company has implemented a transformation program with initiatives focused on its operations, growth, and capital. These initiatives are intended to support the Company's objectives with respect to patient access and experience, customer and partner engagement, financial sustainability, and employee well-being. The Company is receiving support from a globally recognized tr

    8/12/22 5:56:00 PM ET
    $AKU
    $ELV
    $SGRY
    Medical Specialities
    Health Care
    Hospital/Nursing Management